Home › Kanser sa Ovary › California › Mountain View
Pag-aaral pangklinika para sa Kanser sa Ovary sa Mountain View, CA
19 pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Mountain View (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi ang layo
- VA Palo Alto Health Care System, Palo Alto · 5 mi ang layo
A Study of PHST001 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Stanford University School of Medicine, Palo Alto · 5 mi ang layo
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Nagre-recruitPhase 2/3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi ang layo
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Nagre-recruitObservasyonal na pag-aaral
- Stanford University, Palo Alto · 5 mi ang layo
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Nagre-recruitPhase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi ang layo
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
- Stanford University Medical Center, Stanford · 5 mi ang layo
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
Nagre-recruitPhase 1
- Stanford University, Palo Alto · 5 mi ang layo
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Stanford, Palo Alto · 5 mi ang layo
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi ang layo
- at 1 pa
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Nagre-recruitPhase 2
- 150, Palo Alto · 5 mi ang layo
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Nagre-recruitPhase 3
- Palo Alto Medical Foundation, Palo Alto · 5 mi ang layo
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Stanford University, Stanford · 5 mi ang layo
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Nagre-recruitPhase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi ang layo
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Nagre-recruitObservasyonal na pag-aaral
- Stanford University School of Medicine, Stanford · 5 mi ang layo
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Nagre-recruitPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Nagre-recruitPhase 3
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · 5 mi ang layo
- Stanford Women's Cancer Center, Palo Alto · 5 mi ang layo
- Stanford Hospital, Palo Alto · 5 mi ang layo
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Nagre-recruitPhase 2
- Stanford Cancer Center, Palo Alto · 5 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Stanford · 5 mi ang layo
Pag-aaral para sa Kanser sa Ovary sa ibang lungsod
- Houston, TX89 pag-aaral
- New York City, NY70 pag-aaral
- Boston, MA61 pag-aaral
- Los Angeles, CA50 pag-aaral
- Nashville, TN49 pag-aaral
- Arlington, VA46 pag-aaral
- Philadelphia, PA45 pag-aaral
- Columbus, OH39 pag-aaral
- St. Louis, MO38 pag-aaral
- Chicago, IL36 pag-aaral
- Pittsburgh, PA31 pag-aaral
- San Antonio, TX31 pag-aaral
Iba pang pag-aaral sa Mountain View
- Kanser (lahat ng uri)39 pag-aaral
- Kanser sa Suso26 pag-aaral
- Metastatic Cancer25 pag-aaral
- Non-Small Cell Lung Cancer21 pag-aaral
- Acute Myeloid Leukemia19 pag-aaral
- Autism Spectrum Disorder17 pag-aaral
- Kanser sa Baga17 pag-aaral
- Pagkabigo ng Puso15 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Autism13 pag-aaral
- Acute Lymphoblastic Leukemia13 pag-aaral
- Colorectal Cancer13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 7, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.